4.8 Article

NSMCE2 suppresses cancer and aging in mice independently of its SUMO ligase activity

期刊

EMBO JOURNAL
卷 34, 期 21, 页码 2604-2619

出版社

WILEY
DOI: 10.15252/embj.201591829

关键词

NSMCE2; SMC5/6; mouse models; SUMO; chromosome segregation

资金

  1. Fundacion Botin
  2. Banco Santander through its Santander Universities Global Division
  3. MINECO [SAF2011-23753, SAF2014-57791-REDC, BFU2013-49153P]
  4. Howard Hughes Medical Institute
  5. European Research Council [ERC-617840]
  6. Worldwide Cancer Research [12-0229] Funding Source: researchfish

向作者/读者索取更多资源

The SMC5/6 complex is the least understood of SMC complexes. In yeast, smc5/6 mutants phenocopy mutations in sgs1, the BLM ortholog that is deficient in Bloom's syndrome (BS). We here show that NSMCE2 (Mms21, in Saccharomyces cerevisiae), an essential SUMO ligase of the SMC5/6 complex, suppresses cancer and aging in mice. Surprisingly, a mutation that compromises NSMCE2-dependent SUMOylation does not have a detectable impact on murine lifespan. In contrast, NSMCE2 deletion in adult mice leads to pathologies resembling those found in patients of BS. Moreover, and whereas NSMCE2 deletion does not have a detectable impact on DNA replication, NSMCE2-deficient cells also present the cellular hallmarks of BS such as increased recombination rates and an accumulation of micronuclei. Despite the similarities, NSMCE2 and BLM foci do not colocalize and concomitant deletion of Blm and Nsmce2 in B lymphocytes further increases recombination rates and is synthetic lethal due to severe chromosome mis-segregation. Our work reveals that SUMO- and BLM-independent activities of NSMCE2 limit recombination and facilitate segregation; functions of the SMC5/6 complex that are necessary to prevent cancer and aging in mice.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

A truncating variant of RAD51B associated with primary ovarian insufficiency provides insights into its meiotic and somatic functions

Monica M. Franca, Yazmine B. Condezo, Maeva Elzaiat, Natalia Felipe-Medina, Fernando Sanchez-Saez, Sergio Munoz, Raquel Sainz-Urruela, M. Rosario Martin-Hervas, Rodrigo Garcia-Valiente, Manuel A. Sanchez-Martin, Aurora Astudillo, Juan Mendez, Elena Llano, Reiner A. Veitia, Berenice B. Mendonca, Alberto M. Pendas

Summary: A homozygous RAD51B variant was identified in sisters with POI, leading to DNA repair defects and reduced crossovers. This variant also affected RAD51B interactions and replication fork progression, indicating a role in somatic genome stability maintenance.

CELL DEATH AND DIFFERENTIATION (2022)

Article Biochemistry & Molecular Biology

Stress-triggered hematopoietic stem cell proliferation relies on PrimPol-mediated repriming

Kurt Jacobs, Cyril Doerdelmann, Jana Krietsch, Daniel Gonzalez-Acosta, Nicolas Mathis, Saul Kushinsky, Estrella Guarino, Carmen Gomez-Escolar, Dolores Martinez, Jonas A. Schmid, Peter J. Leary, Raimundo Freire, Almudena R. Ramiro, Christine M. Eischen, Juan Mendez, Massimo Lopes

Summary: The mechanisms linking stem cell division to tumorigenesis are still not well understood. This study reveals that DNA damage associated with hematopoietic stem and progenitor cell proliferation induced by simulated viral infection is restricted to hematopoietic stem cells and these cells can rewire their DNA damage response. Further experiments demonstrate that fine-tuning the plasticity of replication forks is essential for supporting stem cell functionality during proliferation stimuli.

MOLECULAR CELL (2022)

Editorial Material Oncology

Emerging concepts in drug discovery for cancer therapy

Matilde Murga, Oscar Fernandez-Capetillo

Summary: These are exciting times to be involved in biomedical research, especially in the field of cancer drug discovery. The transition from scientific hypothesis to testable therapy is faster than ever, aided by the emergence of new technologies. This thematic issue provides an overview of recent advances and challenges in cancer drug development, offering a broad and updated perspective for those interested in developing cancer therapies.

MOLECULAR ONCOLOGY (2022)

Review Biochemistry & Molecular Biology

Targeting the nucleolus as a therapeutic strategy in human disease

Alba Corman, Oleksandra Sirozh, Vanesa Lafarga, Oscar Fernandez-Capetillo

Summary: The nucleolus is where ribosome biogenesis takes place, which is one of the most resource-intensive processes in eukaryotic cells. It is highly responsive to growth signaling and nucleolar insults, collectively known as nucleolar stress. Nucleolar alterations are a prominent feature in various human diseases, including cancer and neurodegeneration, and are also associated with aging. There have been numerous efforts to develop compounds targeting different aspects of nucleolar activity. This article provides an overview of therapeutic opportunities and current therapies for targeting nucleoli in different pathologies.

TRENDS IN BIOCHEMICAL SCIENCES (2023)

Article Cell Biology

Regulation of Claspin by the p38 stress-activated protein kinase protects cells from DNA damage

Arnau Ulsamer, Adrian Martinez-Limon, Sina Bader, Sara Rodriguez-Acebes, Raimundo Freire, Juan Mendez, Eulalia de Nadal, Francesc Posas

Summary: The stress-activated protein kinases (SAPKs) and their functional homologs, such as Mrc1 and Claspin, play a protective role in preventing DNA damage during S-phase in both yeast and mammals.

CELL REPORTS (2022)

Article Biochemistry & Molecular Biology

New regulators of the tetracycline-inducible gene expression system identified by chemical and genetic screens

Valeria Colicchia, Maria Haggblad, Oleksandra Sirozh, Bartlomiej Porebski, Mirela Balan, Xuexin Li, Louise Lidemalm, Jordi Carreras-Puigvert, Daniela Huhn, Oscar Fernandez-Capetillo

Summary: The tetR-regulated system was used to construct a human osteosarcoma cell line for inducible expression of TDP-43. Chemical screening with FDA-approved drugs identified compounds that prevented TDP-43 toxicity, but further experiments showed that these compounds inhibited doxycycline-dependent TDP-43 expression. A CRISPR/Cas9 screen revealed epigenetic regulators as potential modifiers of TDP-43 toxicity. However, G9a inhibition or TRIM28 loss also prevented doxycycline-dependent TDP-43 expression.

FEBS OPEN BIO (2022)

Review Biochemistry & Molecular Biology

Hallmarks of aging: An expanding universe

Carlos Lopez-Otin, Maria A. Blasco, Linda Partridge, Manuel Serrano, Guido Kroemer

Summary: Aging is driven by hallmarks that manifest with age, accelerate aging when accentuated experimentally, and can be decelerated, stopped, or reversed with therapeutic interventions. The twelve proposed hallmarks of aging include genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient-sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation, and dysbiosis. These hallmarks are interconnected with each other and with the recently proposed hallmarks of health.
Article Biochemistry & Molecular Biology

3D chromatin connectivity underlies replication origin efficiency in mouse embryonic stem cells

Karolina Jodkowska, Vera Pancaldi, Maria Rigau, Ricardo Almeida, Jose M. Fernandez-Justel, Osvaldo Grana-Castro, Sara Rodriguez-Acebes, Miriam Rubio-Camarillo, Enrique Carrillo-de Santa Pau, David Pisano, Fatima Al-Shahrour, Alfonso Valencia, Maria Gomez, Juan Mendez

Summary: In this study, the authors analyzed the activity of origins in mouse embryonic stem cells and examined their response to replicative stress. They found that stressed origins were also active in a small fraction of cells during normal S phase, and stress increased their activation frequency. The study also identified that origin efficiency is proportional to the proximity to transcriptional start sites and the number of contacts established between origin-containing chromatin fragments.

NUCLEIC ACIDS RESEARCH (2022)

Article Biochemistry & Molecular Biology

Telomerase deficiency and dysfunctional telomeres in the lung tumor microenvironment impair tumor progression in NSCLC mouse models and patient-derived xenografts

Sergio Pineiro-Hermida, Giuseppe Bosso, Raul Sanchez-Vazquez, Paula Martinez, Maria A. Blasco

Summary: Non-small cell lung cancer (NSCLC) is a leading cause of cancer death, and tumor progression is influenced by the interaction between cancer cells and the tumor microenvironment. Increased copy number and mRNA expression of TERT, a catalytic subunit of telomerase, is associated with decreased survival in NSCLC patients. Targeting telomeres may be an effective therapeutic approach in NSCLC treatment.

CELL DEATH AND DIFFERENTIATION (2023)

Article Multidisciplinary Sciences

RHOJ controls EMT-associated resistance to chemotherapy

Maud Debaugnies, Sara Rodriguez-Acebes, Jeremy Blondeau, Marie-Astrid Parent, Manuel Zocco, Yura Song, Viviane de Maertelaer, Virginie Moers, Mathilde Latil, Christine Dubois, Katia Coulonval, Francis Impens, Delphi Van Haver, Sara Dufour, Akiyoshi Uemura, Panagiota A. Sotiropoulou, Juan Mendez, Cedric Blanpain

Summary: This study reveals that cancer cells undergoing EMT are highly resistant to various anti-cancer therapies. RHOJ, a small GTPase preferentially expressed in EMT cancer cells, controls resistance to therapy by enhancing the response to replicative stress and activating the DNA-damage response. RHOJ interacts with proteins that regulate nuclear actin, and inhibition of actin polymerization sensitizes EMT tumor cells to chemotherapy-induced cell death in a RHOJ-dependent manner.

NATURE (2023)

Article Cell Biology

miR-28-based combination therapy impairs aggressive B cell lymphoma growth by rewiring DNA replication

Teresa Fuertes, Emigdio Alvarez-Corrales, Carmen Gomez-Escolar, Patricia Ubieto-Capella, Alvaro Serrano-Navarro, Antonio de Molina, Juan Mendez, Almudena R. Ramiro, Virginia G. de Yebenes

Summary: The therapeutic potential of miR-28, a tumor suppressor, was analyzed for DLBCL. It was found that combination therapy with miR-28 and ibrutinib enhanced the anti-tumor effects by impairing DNA replication. The downregulation of the miR-28-plus-ibrutinib gene signature was associated with better survival in ABC-DLBCL patients.

CELL DEATH & DISEASE (2023)

Article Cell Biology

Short telomeres in alveolar type II cells associate with lung fibrosis in post COVID-19 patients with cancer

Paula Martinez, Raul Sanchez-Vazquez, Arpita Saha, Maria S. Rodriguez-Duque, Sara Naranjo-Gonzalo, Joy S. Osorio-Chavez, Ana V. Villar-Ramos, Maria A. Blasco

Summary: The severity of COVID-19 increases with age, suggesting that organismal aging contributes to its fatality. Previous studies have shown that COVID-19 severity is correlated with shorter telomeres in patient's leukocytes. Lung injury is a prominent feature of acute SARS-CoV-2 infection, which can progress to lung fibrosis. In this study, we found that post-COVID-19 patients have shorter telomeres and increased lung fibrosis compared to age-matched controls with lung cancer, suggesting a link between short telomeres in ATII cells and long-term lung fibrosis in post-COVID-19 patients.

AGING-US (2023)

暂无数据